Related Articles
Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer
Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
From AR to c-Met: Androgen deprivation leads to a signaling pathway switch in prostate cancer cells
Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation